Complete resolution of erythrodermic psoriasis with first-line apremilast monotherapy

Erythrodermic psoriasis (EP) is the most serious type of psoriasis with high morbidity and mortality. First-line recommended therapies for EP, cyclosporine and infliximab have significant adverse effects. Cyclosporine increases the risk of hypertension, leucopenia, infections and renal failure. Infl...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMJ Case Rep
Main Authors: Krishnamoorthy, Geetha, Kotecha, Aditya, Pimentel, Jason
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2019
Teme:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6357920/
https://ncbi.nlm.nih.gov/pubmed/30709830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-226959
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki